Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1996;93:2052-2058

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Münzel, T.
Right arrow Articles by Bassenge, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Münzel, T.
Right arrow Articles by Bassenge, E.

(Circulation. 1996;93:2052-2058.)
© 1996 American Heart Association, Inc.


Articles

Long-term Angiotensin-Converting Enzyme Inhibition With High-Dose Enalapril Retards Nitrate Tolerance in Large Epicardial Arteries and Prevents Rebound Coronary Vasoconstriction In Vivo

Thomas Münzel, MD; Eberhard Bassenge, MD

From the Medizinische Klinik III, Division of Cardiology (T.M.) and the Institute for Applied Physiology (E.B.), University of Freiburg (Germany).

Correspondence to Thomas Münzel, MD, Universitätsklinik Freiburg, Medizinische Klinik III, Hugstetterstr 55, 79106 Freiburg, Germany.

Background Rebound myocardial ischemia develops in patients with unstable or stable angina pectoris after sudden cessation of nitroglycerin therapy. Long-term nitroglycerin infusion is associated with increases in plasma renin activity and catecholamine release rates, both of which may lead to excess angiotensin II and {alpha}-adrenergic–mediated vasoconstriction, particularly on withdrawal of nitroglycerin.

Methods and Results Chronically instrumented dogs were treated for 5 days with nitroglycerin (1.5 µg·kg-1·min-1 IV) alone or in combination with the angiotensin-converting enzyme (ACE) inhibitor enalapril (0.1 mg/kg two times daily or 1 mg/kg). With long-term nitroglycerin therapy, the left anterior circumflex artery was maximally dilated 4 hours after the start of nitroglycerin infusion (9.5±0.6%) and returned to baseline levels within the third day of treatment (baseline, 2.52±0.07 mm; day 3, 2.55±0.07 mm; P=NS), indicating a complete loss of nitroglycerin-induced coronary vasodilatation. Nitroglycerin infusion also was accompanied by a transient increase in plasma renin activity. Sudden withdrawal of nitroglycerin infusion caused a progressive constriction of the left anterior circumflex artery, which peaked 4 hours after nitroglycerin infusion cessation (-7.8±0.2%). This occurred in the absence of elevated plasma renin activity. Concomitant treatment with high-dose enalapril (1 mg·kg-1·d-1) markedly reduced the degree of tolerance and prevented the rebound constriction on cessation of nitroglycerin therapy.

Conclusions Long-term ACE inhibition with high-dose enalapril reduces nitroglycerin tolerance and prevents rebound vasoconstriction in coronary arteries. These phenomena were not associated with an activated circulating renin-angiotensin system. This observation suggests that during long-term nitroglycerin treatment, intrinsic abnormalities of the vascular smooth muscle may have developed that are suppressed by concomitant ACE inhibitor therapy. The present study also favors a combination of nitroglycerin and ACE inhibitors to maintain nitrate sensitivity of the vasculature during long-term nitroglycerin treatment.


Key Words: nitroglycerin • circulation • pharmacology




This article has been cited by other articles:


Home page
Circ. Res.Home page
H. J. Knot
Nitrate Tolerance in Hypertension: New Insight Into a Century-Old Problem
Circ. Res., October 31, 2003; 93(9): 799 - 801.
[Full Text] [PDF]


Home page
CirculationHome page
T. Gori and J. D. Parker
The Puzzle of Nitrate Tolerance: Pieces Smaller Than We Thought?
Circulation, October 29, 2002; 106(18): 2404 - 2408.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
L. T. McGrath, L. Dixon, D. R. Morgan, and G. E. McVeigh
Production of 8-epi prostaglandin F2{alpha} in human platelets during administration of organic nitrates
J. Am. Coll. Cardiol., August 21, 2002; 40(4): 820 - 825.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. Hebert and J. Y. T. Lam
Nitroglycerin rebound associated with vascular, rather than platelet, hypersensitivity
J. Am. Coll. Cardiol., December 1, 2000; 36(7): 2311 - 2316.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. Munzel, H. Mollnau, M. Hartmann, C. Geiger, M. Oelze, A. Warnholtz, A. H. Yehia, U. Forstermann, and T. Meinertz
Effects of a nitrate-free interval on tolerance, vasoconstrictor sensitivity and vascular superoxide production
J. Am. Coll. Cardiol., August 1, 2000; 36(2): 628 - 634.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Kurz, U. Hink, G. Nickenig, A. B. Borthayre, D. G. Harrison, and T. Munzel
Evidence for a Causal Role of the Renin-Angiotensin System in Nitrate Tolerance
Circulation, June 22, 1999; 99(24): 3181 - 3187.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
W. M. Weightman, N. M. Gibbs, M. R. Sheminant, E. G. Whitford, B. D. Mahon, and M. A. J. Newman
Drug Therapy Before Coronary Artery Surgery: Nitrates Are Independent Predictors of Mortality and {beta}-Adrenergic Blockers Predict Survival
Anesth. Analg., February 1, 1999; 88(2): 286 - 286.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. R. A. Caramori, A. G. Adelman, E. R. Azevedo, G. E. Newton, A. B. Parker, and J. D. Parker
Therapy with nitroglycerin increases coronary vasoconstriction in response to acetylcholine
J. Am. Coll. Cardiol., December 1, 1998; 32(7): 1969 - 1974.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
H. Watanabe, M. Kakihana, S. Ohtsuka, and Y. Sugishita
Preventive effects of carvedilol on nitrate tolerance--a randomized, double-blind, placebo-controlled comparative study between carvedilol and arotinolol
J. Am. Coll. Cardiol., November 1, 1998; 32(5): 1201 - 1206.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Zanzinger, J. Czachurski, and H. Seller
Impaired Modulation of Sympathetic Excitability by Nitric Oxide After Long-term Administration of Organic Nitrates in Pigs
Circulation, June 16, 1998; 97(23): 2352 - 2358.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Watanabe, M. Kakihana, S. Ohtsuka, and Y. Sugishita
Randomized, Double-Blind, Placebo-Controlled Study of Ascorbate on the Preventive Effect of Nitrate Tolerance in Patients With Congestive Heart Failure
Circulation, March 10, 1998; 97(9): 886 - 891.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. D. Parker and J. O. Parker
Nitrate Therapy for Stable Angina Pectoris
N. Engl. J. Med., February 19, 1998; 338(8): 520 - 531.
[Full Text] [PDF]


Home page
CirculationHome page
H. Watanabe, M. Kakihana, S. Ohtsuka, and Y. Sugishita
Randomized, Double-Blind, Placebo-Controlled Study of Supplemental Vitamin E on Attenuation of the Development of Nitrate Tolerance
Circulation, October 21, 1997; 96(8): 2545 - 2550.
[Abstract] [Full Text]


Home page
CirculationHome page
D. Hebert, J.-X. Xiang, and J. Y.T. Lam
Persistent Inhibition of Platelets During Continuous Nitroglycerin Therapy Despite Hemodynamic Tolerance
Circulation, March 4, 1997; 95(5): 1308 - 1313.
[Abstract] [Full Text]